Stock BAX BAXTER INTERNATIONAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Baxter International Inc.

Equities

BAX

US0718131099

Real-time Estimate Cboe BZX
Other stock markets
 12:35:59 2024-04-16 pm EDT 		5-day change 1st Jan Change
39.84 USD -0.51% Intraday chart for Baxter International Inc. -7.07% +2.95%
Apr. 15 Exact Sciences Names Aaron Bloomer CFO MT
Apr. 11 Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Exact Sciences Names Aaron Bloomer CFO
MT
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
BU
Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S
CI
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
BU
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period
MT
Citigroup Raises Price Target on Baxter International to $44 From $41, Keeps Neutral Rating
MT
Baxter International Receives US FDA Clearance for Novum IQ Large Volume Infusion Pump
MT
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
BU
Baxter International Inc. Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
CI
Baxter International : 2023 Proxy Statement Supplement
PU
Baxter to Host Annual Meeting of Stockholders in Virtual Format
BU
Baxter International Files Definitive Proxy Statement with Securities and Exchange Commission
CI
Baxter International Inc. Enters into Fourth Amendment to the Existing $4.0 Billion Term Loan Credit Facility
CI
Baxter International Receives a Shareholder Proposal from John Chevedden
CI
Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data
RE
Baxter International Now Considering Sale of Kidney Care Business to Private Equity Investors
MT
Dialysis firms gain as Ozempic kidney trial data disappoints
RE
Transcript : Baxter International Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 04:00 PM
Baxter International Provides an Update on the Planned Separation of its Kidney Care Business
CI
Baxter International to Present at Raymond James 45th Annual Institutional Investors Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAX Stock
  4. News Baxter International Inc.